CN Patent

CN105308043B — 丙型肝炎药物的晶型及其制备方法、其药物组合物和用途

Assigned to Hangzhou Lingye Pharmaceutical Technology Co ltd · Expires 2018-01-30 · 8y expired

What this patent protects

一种丙型肝炎(HCV)药物TMC435的新晶型，以及其制备方法、其药物组合物及其在制备用于治疗和/或预防丙型肝炎病毒感染的药物中的用途。

USPTO Abstract

一种丙型肝炎(HCV)药物TMC435的新晶型，以及其制备方法、其药物组合物及其在制备用于治疗和/或预防丙型肝炎病毒感染的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105308043B
Jurisdiction
CN
Classification
—
Expires
2018-01-30
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Lingye Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.